AzPA ANNUAL CONVENTION

JUNE 14-17TH | PHOENIX, AZ

THEME: INGREDIENTS FOR SUCCESS!

This four-day annual conference provides over fifteen (15) hours of continuing education, recognition, and networking opportunities for pharmacy professionals of all practice settings.

AzPA Psychiatric Certificate Program

JUNE 14th | PHOENIX, AZ

A practice-based activity designed for pharmacists in all practice settings. The intent of this training program is to provide additional training in the area of psychiatric pharmacy to enhance pharmacists’ clinical knowledge that can be applied directly to the patients they serve.

AzPA Immunization Certificate Program

JUNE 14th | PHOENIX, AZ

This program is an interactive educational program that provides pharmacists and student pharmacists with the skills necessary to become primary sources for vaccine advocacy, education, and administration.

APhA Pharmacist & Patient-Centered Diabetes Care Program

JUNE 14th | PHOENIX, AZ

Gain experience evaluating and adjusting drug therapy regimens for patients with type 1 & type 2 diabetes, counseling patients about lifestyle interventions, analyzing and interpreting self-monitoring of blood glucose results, and assessing the overall health status of patients to identify needed monitoring and interventions.

Pain Management Certificate Program

JULY 28TH | VIRTUAL PROGRAM

Featuring a new kind of Certificate Program! This entire learning experience can be done in the comfort of your own home. It consists of a Home Study Component and a Live Webinar - That's it!

Educate

Learn with us

Advocate

Discover your voice

Connect

Get involved! Serve on a team

RSS AzPA Pharmacy Flash

  • Nonopioid drug approved by FDA for opioid withdrawal symptons
    Federal regulators recently approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids. The U.S. Food and Drug Administration expedited approval of Lucemyra to help combat the U.S. opioid epidemic.
  • Popular drug designed for schizophrenia reveals issues of 'off-label' use
    The first warning came a dozen years ago, when the Food and Drug Administration accused drug company AstraZeneca of “false or misleading” information about health risks in marketing its blockbuster medication Seroquel, an antipsychotic developed to treat schizophrenia but increasingly prescribed “off label” for insomnia.
  • What are copay accumulator programs?
    Retail pharmacists and specialty pharmacists working in the trenches may have heard whispers about something called "copay accumulator programs." But with long lines at the register, phones ringing off the hook, 30 more flu shots to give and a jammed printer…I can understand why you haven’t had time to read up on them. I’m a […]

Upcoming Events

Upcoming Events

AzPA Annual Convention

06/14/2018 - 06/17/2018

Sheraton Grand at Wild Horse Pass

Annual Convention Exhibitor Registration

06/15/2018 - 06/16/2018

Sheraton Grand at Wild Horse Pass